Tokyo, March 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061067) titled 'Safety Confirmation Study on long-term of Supplement Containing Bee Larva in Healthy Subjects' on March 27.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Yamada Bee Company, Inc.
Condition:
Condition - Healthy Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the safety of long-term intake (4 capsules/day for 12 weeks) of a capsule-type supplement containing mainly honeybee larvae and a small amount of roya...